Combination of Olanzapine Pamoate with Melatonin and Metformin: Quantitative Changes in Rat Adipose Tissue

Olanzapine is one of the atypical antipsychotics widely used in the treatment of schizophrenia and has been associated with metabolic changes as adverse effects, including hyperglycemia, dyslipidemia, and weight gain. In a batch of adult female Wistar rats, we studied the prolonged-release intramusc...

Descripción completa

Detalles Bibliográficos
Autores principales: MIRON, IC, POPESCU, F, ENĂCHESCU, V, CRISTEA, OM, STOICĂNESCU, EC, AMZOIU, E, AMZOIU, M, POPESCU, FD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 201
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014984/
https://www.ncbi.nlm.nih.gov/pubmed/32110439
http://dx.doi.org/10.12865/CHSJ.45.04.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014984/
https://www.ncbi.nlm.nih.gov/pubmed/32110439
http://dx.doi.org/10.12865/CHSJ.45.04.05

Ejemplares similares